Clinical trial Recruiting at 3 sites Interventional Ages 21 and up

Robotically repairing ventral or inguinal hernias using OviTex mesh

Official title: A Prospective Study Evaluating the Clinical Outcomes of Ventral or Inguinal Hernias Treated Robotically With OviTex® Reinforced Tissue Matrix

Run by Tela Bio Inc · NCT04779918 · Data updated 2026-11-12

This study is testing whether using a special mesh called OviTex in robotic surgery can help people with ventral or inguinal hernias recover better and avoid complications.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment160 (estimated)
SponsorTela Bio Inc
Industry-sponsored
Locations10 sites (Mobile, Alabama and 9 other locations)
StatusRecruiting
StartedApril 29, 2021
Main results expectedMarch 30, 2027
Study endsDecember 30, 2029
Registry record updatedMay 5, 2026
Trial IDNCT04779918 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21 and older with ventral or inguinal hernias requiring surgical repair using an implant.

Probably not a fit

Patients with hernias that do not require surgical repair or those with contraindications for robotic surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the post-operative complications and recurrence rates of ventral or inguinal hernias treated with OviTex mesh using a robotic surgical approach. Up to 160 participants will be enrolled across 20 sites, all receiving the OviTex Reinforced Tissue Matrix for their hernia repair. The study aims to gather data on the effectiveness and safety of this specific mesh in robotic surgeries.

Why it matters

Potential benefit: If successful, this study could lead to improved surgical outcomes and reduced recurrence rates for patients undergoing hernia repair.

How similar studies have gone: Other studies have shown promising results with robotic hernia repairs, but the specific use of OviTex mesh in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Subject suffers from a ventral or inguinal hernia that requires surgical repair with the use of an implant to reinforce or replace weakened or missing tissue.
2. The patient is scheduled for an elective robotic approach with the use of OviTex LPR, OviTex Core Permanent, OviTex 1S Permanent, or OviTex IHR.
3. The size of the implant needed for repair is expected to be less than or equal to 15 x 25 cm for OviTex LPR and 25 x 40 cm for OviTex Core Permanent and OviTex 1S Permanent, with no size limitation for OviTex IHR.
4. Subject meets CDC/SSI Wound Classification Class I (Clean), Class II (Clean-Contaminated) or Class III (Contaminated) criteria.
5. Subject is willing and able to sign an informed consent for the study and has signed the IRB approved Informed Consent form for this study.
6. Subject is able to complete Quality of Life (QoL) and pain questionnaires.
7. Subject is at least 21 years old.
8. Subject is willing to comply and able to participate fully in, and for the full duration of, the study including follow-up requirements.

Exclusion Criteria at Baseline:

1. Subject has a BMI of \> 40
2. Subject meets CDC/SSI Wound Classification Class IV (Dirty-Infected) criteria
3. Subject is female and is pregnant or plans to become pregnant during the course of the study.
4. Subject has a life expectancy of \< 2 years making it unlikely that the subject will successfully achieve two-year follow-up.
5. Subject has recent history of drug or alcohol abuse (in last 3 years).
6. Subject has an allergy to ovine-derived products.
7. Subject has participated in another clinical trial within the past 30 days or is currently involved in another clinical trial.
8. Subject has a strangulated hernia.

Exclusion Criteria Intraoperative:

1. Subject requires implant that cannot be introduced into the surgical site during the procedure via port or an existing incision.
2. Subject unable to receive OviTex LPR, OviTex Core Permanent, OviTex 1S Permanent, or OviTex IHR at time of surgery.

Where it's running

  • University of South Alabama
    Mobile, Alabama, United States
    Recruiting
  • University of Louisville
    Louisville, Kentucky, United States
    Recruiting
  • Munson Healthcare
    Traverse City, Michigan, United States
    Recruiting
  • SurgOne
    Denver, Colorado, United States
    Active not recruiting
  • GenesisCare
    Destin, Florida, United States
    Terminated
  • Surgical Healing Arts Center
    Fort Myers, Florida, United States
    Terminated
Show 4 more locations
  • St. Luke's Hospital
    Overland Park, Kansas, United States
    Active not recruiting
  • St. Francis Hospital
    Roslyn, New York, United States
    Withdrawn
  • Mohawk Valley Health System
    Utica, New York, United States
    Withdrawn
  • Houston Methodist
    Houston, Texas, United States
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.